What is Xaira Therapeutics worth?
$3.5Blast known valuation
Xaira Therapeutics last raised $1.0B in its Series A (Apr 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Xaira Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2024 | Series A | $1.0B | ▮ | ▮ |
How Xaira Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Xaira Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Xaira Therapeutics worth?
- Xaira Therapeutics's last known valuation is $3.5B.
- How much has Xaira Therapeutics raised?
- Xaira Therapeutics has raised $1.3B in total funding across 1 recorded rounds.
- When did Xaira Therapeutics last raise?
- Xaira Therapeutics last raised in Apr 2024 (Series A), raising $1.0B.